NYSE:PFE A hammer signaled reversal for $PFE. Shortly after price broke out of the downtrend resistance. Four inside bars have formed during period of consolidation. $PFE looks primed for sharp movement. Catalyst would likely be FDA / CDC approval/rejection of its Covid vaccination for children, expected in 4th week of Feb. Application is for 2 doses,...
The Canadian dollar is flat on Wednesday, trading at 1.2685 in the North American session. Canada's GDP outperformed in November, but the positive news wasn't enough to move the sleepy Canadian dollar. GDP expanded by 0.6%, above the consensus of 0.4%. The growth was broad-based across the economy and GDP has now pushed above its pre-pandemic level in February...
The Aussie has rebounded nicely this week, recovering half the losses from last week, when it tumbled 2.5%. AUD/USD has edged higher and is trading just below the 0.71 level in the European session. There were no surprises from the RBA policy meeting earlier today. The central bank held the Cash Rate at a record low of 0.10% and announced that it would wind up...
The OMX C25 shares had a very good bullish trend from the beginning of COVID-recession. Now the shares just finished a shoulder head shoulder bullish formation and is now testing at the support level. Now it is very possible that the shares are going to raise and reach the resistance level. Therefore we now could get a potential bullish trend where it can raise...
ARDS Aridis Pharmaceuticals received a grant award from the Bill & Melinda Gates Foundation to evaluate the application of Aridis' inhaled formulation technology to deliver cost-effective monoclonal antibodies (mAbs) against influenza and SARS-CoV2. Aridis Pharmaceuticals is a stock with a mk cap of only 28.249Mil. Before Aridis, Bill & Melinda Gates Foundation...
Hi everyone 👋🏽 🕊 Wish y'all have a profitable lifestyle 🍀 📌 BTCUSDT- Daily Time Frame - Heiken Ashi 📌 Supply Demand - Wave Analysis - Support Resistance 📍BTCUSDT chart is looking so complicated nowadays... with having so many NEWS and such different ideas about the price's future 📍Let's go straight to the point, from Elliott wave point of view we may see a...
Speculation for Macro: - State of Emergency and lockdown for 10 weeks due to Omicron variant. - Bear market until Feb 2022. "Move fast, move hard" - Naftali Bennett GLHF - DPT
The trend continues to be your friend until the very end. This is 2 day chart that I posted in the beginning of the year that continues to be in play since the COVID meltdown in early 2020. Price has been in a strong uptrend with very few pullbacks. Even the pullbacks result in dramatic reversals and pumps to the upside. Here is where it gets interesting. We...
This one may be a bit risky but valuations are below the historical average and there's is some possibility that the divisions we've been seeing over COVID vaccines leads to a more local-focused population. People getting back to what's real and the issues that actually affect them in order to recalibrate to a sense of normalcy. If there is a tech hangover, I...
The Thai Baht has been cautiously gaining ground against the US Dollar since December despite recent volatility in stock markets. In fact, USD/THB recently broke under a key rising trendline from early 2021, confirming the breakout. Key support below appears to be the 200-day Simple Moving Average. Tourism is a key component of Thailand's economy, which has been...
They have at their disposal the technical analysis of Novacyt, it has great bullish potential, they have marked resistance and support. I hope it will help you. Sincerely, L.E.D. In Spain on 01/20/2022
I made a personal TA on NYSE:PFE using FIB retracements to define when to buy the current pullback reversal. PFE is currently in a very clear uptrend an its previous pullbacks "reversed" at aroung 50%-61.8% FIB so i think that this current pullback is going to reverse at around 50%. Before buying: Check Rsi bounceoff and SMA positionning to form a...
Well would you look at that, a Bitcoin analysis. Opting for the Higher time frames here, from the chart above we have 4 trendlines, all of which have played significant roles in bitcoin achieveing it's current price action. Looking at the trendline that initiated the bounce on November in the year 2011, bitcoin has found itself at the trendline once again after...
A week later from the last update, we see a massive spike in the COVID cases. First, as expected since Oct 20, at the turn of the year, the next wave is set upon India. Second, this wave is very sudden and much bigger in magnitude, particularly in the last week. This will translate to a longer tailing off in the months to come. Third, a new trajectory is...
Hello All! Gold is still consolidating in the weekly triangle also following the weekly 200MA. A break out from this triangle will push towards new ATH or search for buys near the supply support levels. A break from support would be bad news for Gold however much less likely due to the current political climate & current events.
The British pound has posted very slight gains on Friday. In the European session, GBP/USD is trading at 1.3720, up 0.09% on the day. The pound is yawning despite better than expected UK data today. GDP jumped 0.9% m/m in November, above the consensus of 0.4%, while Manufacturing Production rose 1.1% m/m, crushing the estimate of 0.2%. Both readings were above...
Analyst Vernon Bernardino from H.C. Wainwright reiterated a buy rating and $19 price target on ARDS: "the cocktail binds to the S2 spike protein subunit, which mediates viral cell membrane fusion in SARS-CoV-2 variants and also binds to the omicron variant with no loss in affinity compared to the original Wuhan strain." Aridis Pharmaceuticals Inc 's monoclonal...
Adagio Therapeutics announced its lead monoclonal antibody has neutralization activity against the Omicron variant of SARS-CoV-2. Adagio is evaluating ADG20 in its global Phase 2/3 clinical trials for prevention and treatment of COVID-19. Adagio is engaging with the FDA regarding protocol updates to its global Phase 2/3 clinical trials. My price target is...